NDC 76489-001

HemaCord

Human Cord Blood Hematopoietic Progenitor Cell

HemaCord is a Intravenous Injection in the Cellular Therapy category. It is labeled and distributed by New York Blood Center. The primary component is Human Cord Blood Hematopoietic Progenitor Cell.

• Product ID: 76489-001_7872bf9e-58ab-0456-e053-2991aa0a18c6
• NDC: 76489-001
• Product Type: Cellular Therapy
• Proprietary Name: HemaCord
• Generic Name: Human Cord Blood Hematopoietic Progenitor Cell
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2011-11-10
• Marketing Category: BLA / BLA
• Application Number: BLA125397
• Labeler Name: New York Blood Center
• Substance Name: HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL
• Active Ingredient Strength: 500000000 1/25mL
• Pharm Classes: Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC],Hematopoietic Stem Cells [CS],Cells, Allogeneic [EXT]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 76489-001-02

1 BAG in 1 CANISTER (76489-001-02) > 25 mL in 1 BAG (76489-001-01)

• Marketing Start Date: 2011-11-10
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 76489-001-01 [76489000101]

HemaCord INJECTION

• Marketing Category: BLA
• Application Number: BLA125397
• Product Type: CELLULAR THERAPY
• Marketing Start Date: 2011-11-10

NDC 76489-001-02 [76489000102]

HemaCord INJECTION

• Marketing Category: BLA
• Application Number: BLA125397
• Product Type: CELLULAR THERAPY
• Marketing Start Date: 2011-11-10

Drug Details

Active Ingredients

Ingredient	Strength
HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL	500000000 1/25mL

Pharmacological Class

• Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]
• Hematopoietic Stem Cells [CS]
• Cells
• Allogeneic [EXT]